The extraordinary advancements made over the past several years in the clinical management of cancer have ushered in a new era of optimism for those afflicted with many cancer types. However, these advancements have also created a highly complex environment for healthcare providers and diagnostic laboratory personnel.
This webinar series will efficiently describe emerging and evolving biomarkers that will be structured to provide a consistent framework for each biomarker. Read more about this series in this JMD article.
Each webinar will feature:
The recordings will be posted as (1) A complete presentation with pre- and post-tests plus available continuing education credit and (2) A series of short microlearning modules (~15 minute videos) that can be reviewed based on need and interest in the science, laboratory applications, and/or clinical implications of each marker.
Click on the icons below to access the full webinar(s), the 15-min microlearning module(s) (MLM), or the practice advance papers .
|BIOMARKERS||FULL WEBINAR||SCIENCE MLM||LABORATORY MLM||CLINICAL MLM||PAPER|
|Being eNRGy Conscious: Understanding NRG1 Fusions|
|EGFR Exon 20 Insertions|
|ERBB2 (HER2) in Colorectal Cancer|
|FLT 3 Mutations and AML|
|Immunoglobulin and T-cell Receptor Gene Sequencing|
|Molecular Diagnostic and Clinical Perspectives on MSI Testing for Cancer|
|Mutational Signatures in Cancer||
|Myeloid Malignancy MRD|
AMA PRA Category 1 Credit(s)™
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.
The ASCP designates this material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™per webinar. Physicians should claim only credit commensurate with the extent of their participation in the activity.
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit per webinar. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.
This webinar series on Emerging and Evolving Biomarkers (EEB) is planned and coordinated by the Emerging and Evolving Biomarkers Content Committee:
Anthony N. Snow, MD, Content Chair (2023)
University of Iowa Hospitals and Clinics, Carver College of Medicine
Kurtis D. Davies, PhD
University of Colorado, Anschutz Medical Campus
Rena Xian, MD
The Johns Hopkins School of Medicine
Jennifer Bynum, MD (T&E Committee Liaison)
And supported by the AMP Training & Education Committee